id: NEW:chronic_liver_disease_to_NEW:covid_19_mortality
name: Chronic Liver Disease â†’ COVID-19 Mortality
from_node:
  node_id: NEW:chronic_liver_disease
  node_name: Chronic Liver Disease
to_node:
  node_id: NEW:covid_19_mortality
  node_name: COVID-19 Mortality
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Chronic liver disease impairs hepatic function, reducing the liver''s ability
  to synthesize proteins essential for immune response and coagulation'
- 'Step 2: Compromised liver function leads to dysregulated immune responses, including
  impaired cytokine regulation and reduced ability to clear pathogens'
- 'Step 3: Pre-existing liver inflammation and fibrosis create a hyperinflammatory
  state that amplifies COVID-19-induced systemic inflammation (cytokine storm)'
- 'Step 4: Impaired hepatic clearance of inflammatory mediators and metabolic dysfunction
  contribute to multi-organ failure in severe COVID-19'
- 'Step 5: Combined hepatic dysfunction and COVID-19 infection result in significantly
  increased risk of severe disease progression and death'
evidence:
  quality_rating: A
  n_studies: 40
  primary_citation: 'Ramya Nagarajan et al. 2022. COVID-19 Severity and Mortality
    Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis. Preventing
    Chronic Disease.'
  supporting_citations: []
description: Chronic liver disease significantly increases the risk of COVID-19 mortality,
  with patients having 2.35 times higher odds of death compared to those without CLD.
  This meta-analysis of 40 studies involving over 900,000 participants demonstrates
  that pre-existing hepatic dysfunction compromises immune responses and exacerbates
  the inflammatory cascade triggered by SARS-CoV-2 infection.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 2.35
    type: odds_ratio
    ci_lower: 1.85
    ci_upper: 3.0
  p_value: null
  sample_size: 908032
moderators:
- name: CLD severity
  direction: strengthens
  strength: moderate
  description: More advanced liver disease (cirrhosis, decompensated liver disease)
    likely associated with greater COVID-19 mortality risk
- name: CLD etiology
  direction: strengthens
  strength: weak
  description: Different underlying causes of CLD (viral, alcoholic, metabolic) may
    differentially affect COVID-19 outcomes
